Mechanism for potential Friedreich's ataxia drug uncovered
Discovery takes researchers one step closer to human clinical trials and could improve understanding of other diseases
29-Sep-2009 -
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, ...
chemistry
chromosomes
clinical trials
+9